Biotech stocks are surging. How investors can play the new drug innovation boom
">
Biotech stocks are surging. How investors can play the new drug innovation boom
Biotech stocks are rallying as clinical wins, M&A and new drug technologies revive the sector. Here are the ETFs and stocks analysts favor.
This article was created based on information from various sources and rewritten for clarity and originality.
